Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
15.64
+0.21 (1.39%)
May 5, 2025, 4:00 PM EDT - Market closed
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $1.01 billion as of May 6, 2025. Its market cap has increased by 90.06% in one year.
Market Cap
1.01B
Enterprise Value
815.83M
1-Year Change
90.06%
Ranking
Category
Stock Price
$15.64
Market Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $1.01B, an increase of 62.27%. That is a compound annual growth rate of 24.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2025 | 1.01B | 65.51% |
| Dec 31, 2024 | 612.65M | 73.31% |
| Dec 29, 2023 | 353.50M | -43.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.45B |
| Johnson & Johnson | 372.94B |
| UnitedHealth Group | 368.47B |
| AbbVie | 346.84B |
| Novo Nordisk | 307.48B |
| Abbott Laboratories | 230.70B |
| AstraZeneca | 221.69B |
| Novartis AG | 221.37B |